Quantoom Biosciences is a full-stack RNA partner for mRNA- and saRNA-based vaccines and therapeutics. Its N-Force toolbox relies on 3 core elements to turn any antigen into a (sa)mRNA-LNP drug product: Ncode for sequence design and optimization, Ntensify® for RNA production and Ncapsulate® for RNA-LNP formulation. Launched in 2023, the Ntensify solution enables fully integrated, scalable RNA production by combining processes, equipment, reagent mixes, and disposables and has gained global adoption, being recognized for performance and ease-of-use. Beyond technology, Quantoom Biosciences assists its partners by providing extensive enabling solutions, ranging from strategic R&D partnerships to sequence design & optimization.
| Website | http://www.quantoom.com |
| Employees | 55 (47 on RocketReach) |
| Founded | 2021 |
| Address | Rue de la Maîtrise 11, Nivelles, Walloon Region 1400, BE |
| Industry | Biotechnology Research |
| Keywords | Reagent Supply, Pharmaceutical Manufacturing, Biotechnology, Drug Development, Rna Therapeutics, Genetic Engineering, Molecular Biology, Bioprocessing, Pharmaceutical Research, Life Sciences, Nucleic Acid, Gene Therapy, Rna Technology, Biotechnology Research, Drug Discovery |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Benchling, EMBL, Invitae, Molecular Devices +40 more (view full list) |
Looking for a particular Quantoom Biosciences employee's phone or email?
Quantoom Biosciences Questions
Jose Castillo is the CEO of Quantoom Biosciences.
47 people are employed at Quantoom Biosciences.
Quantoom Biosciences is based in Nivelles, Walloon Region.
Top Quantoom Biosciences Employees
-
Jose Castillo
CEO at Quantoom Biosciences
Brussels, BE35+ -
2
-
24
-
Marc de Fruytier
Site Manager at Quantoom Biosciences
Nivelles, WAL, BE11 -
David Shofi
IP Counsel at Quantoom Biosciences
Ridgefield, CT, US44
Related Companies
